Literature DB >> 21493813

Conditional VHL gene deletion activates a local NO-VEGF axis in a balanced manner reinforcing resistance to endothelium-targeted glomerulonephropathy.

Taku Morita1, Yoshihiko Kakinuma, Atsushi Kurabayashi, Mikiya Fujieda, Takayuki Sato, Taro Shuin, Mutsuo Furihata, Hiroshi Wakiguchi.   

Abstract

BACKGROUND/AIMS: We have reported that tubular epithelial cell injury caused by renal ischemia-reperfusion is attenuated in conditional VHL knockout (VHL-KO) mice and also that induction of hypoxia-inducible factor (HIF) suppresses angiotensin II-accelerated Habu snake venom (HV) glomerulonephropathy in rats. However, it remains unknown whether VHL knockdown protects glomerular endothelial cells from endothelium-targeted glomerulonephritis. METHODS AND
RESULTS: VHL-KO mice with HV glomerulonephropathy (HV GN) had fewer injured glomeruli, a lower mesangiolysis score and reduced blood urea nitrogen levels. Immunoreactivity of vascular endothelial growth factor (VEGF) in the glomerular capillaries was enhanced by VHL knockdown and was conserved even in VHL-KO mice with HV GN, despite HV-attenuating endothelial VEGF expression in vitro. VHL-KO mice showed enhanced nitric oxide (NO) production in glomerular endothelial cells and tubular cells, associated with activated VEGF expression in the kidney (i.e. an activated NO-VEGF axis). The levels of NO in glomeruli and tubules were conserved even in mice with HV GN. In contrast, suppressing NO production in glomerular endothelial cells by an NO synthase inhibitor, N(ϖ)-nitro-L-arginase, completely blunted the protection of VHL-KO from HV GN. The activated NO-VEGF axis in the kidney of VHL-KO mice was also associated with an elevation in Flk-1 phosphorylation and increased levels of IL-10 and IP-10.
CONCLUSION: Conditional VHL knockdown may enhance the NO-VEGF axis and protect glomerular endothelial cells from HV GN, thereby providing resistance to injury of tubular epithelial cells and glomerular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493813     DOI: 10.1093/ndt/gfr176

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.

Authors:  Alejandro R Chade; Silvia Kelsen
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-22

Review 2.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

3.  VEGF: Potential therapy for renal regeneration.

Authors:  Alejandro R Chade
Journal:  F1000 Med Rep       Date:  2012-01-03

4.  Hydrogen peroxide-inducible clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice.

Authors:  Ariunbold Jamba; Shuji Kondo; Maki Urushihara; Takashi Nagai; Joo-Ri Kim-Kaneyama; Akira Miyazaki; Shoji Kagami
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

5.  Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.

Authors:  Ying Wang; Dan-Qi Chen; Ming-Yu Chen; Kai-Yuan Ji; De-Xuan Ma; Liang-Fu Zhou
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

6.  Conditional VHL gene deletion causes hypoglycemic death associated with disproportionately increased glucose uptake by hepatocytes through an upregulated IGF-I receptor.

Authors:  Atsushi Kurabayashi; Yoshihiko Kakinuma; Taku Morita; Keiji Inoue; Takayuki Sato; Mutsuo Furihata
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.